Bone Marrow Transplantation
"Bone Marrow Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.
| Descriptor ID |
D016026
|
| MeSH Number(s) |
E02.095.147.725.040 E04.936.580.040
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bone Marrow Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Bone Marrow Transplantation".
This graph shows the total number of publications written about "Bone Marrow Transplantation" by people in this website by year, and whether "Bone Marrow Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 47 | 15 | 62 |
| 1995 | 37 | 14 | 51 |
| 1996 | 36 | 15 | 51 |
| 1997 | 34 | 9 | 43 |
| 1998 | 17 | 11 | 28 |
| 1999 | 24 | 4 | 28 |
| 2000 | 22 | 13 | 35 |
| 2001 | 23 | 9 | 32 |
| 2002 | 19 | 11 | 30 |
| 2003 | 10 | 16 | 26 |
| 2004 | 13 | 9 | 22 |
| 2005 | 19 | 8 | 27 |
| 2006 | 7 | 11 | 18 |
| 2007 | 8 | 9 | 17 |
| 2008 | 14 | 5 | 19 |
| 2009 | 11 | 5 | 16 |
| 2010 | 13 | 14 | 27 |
| 2011 | 9 | 14 | 23 |
| 2012 | 12 | 8 | 20 |
| 2013 | 13 | 9 | 22 |
| 2014 | 14 | 15 | 29 |
| 2015 | 17 | 5 | 22 |
| 2016 | 9 | 9 | 18 |
| 2017 | 13 | 7 | 20 |
| 2018 | 6 | 9 | 15 |
| 2019 | 3 | 8 | 11 |
| 2020 | 5 | 10 | 15 |
| 2021 | 3 | 3 | 6 |
| 2022 | 2 | 2 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Marrow Transplantation" by people in Profiles.
-
The effect of ADAMTS13 on graft-versus-host disease. J Cell Mol Med. 2024 Jul; 28(13):e18457.
-
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication. Nat Commun. 2024 Mar 29; 15(1):2749.
-
IL-1? promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells. Blood Adv. 2024 03 12; 8(5):1234-1249.
-
Genetic sex validation for sample tracking in next-generation sequencing clinical testing. BMC Res Notes. 2024 Mar 03; 17(1):62.
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 04; 99(4):785-788.
-
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. Am J Hematol. 2024 04; 99(4):562-569.
-
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood. 2023 06 22; 141(25):3031-3038.
-
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future. Stem Cells Transl Med. 2023 03 03; 12(2):55-71.
-
Red blood cell depletion in small-volume bone marrow processing using manipulation with third-party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems. Transfusion. 2022 09; 62(9):1829-1838.
-
Chlorhexidine gluconate (CHG) foam improves adherence, satisfaction, and maintains central line associated infection rates compared to CHG wipes in pediatric hematology-oncology and bone marrow transplant patients. Pediatr Hematol Oncol. 2023 Mar; 40(2):159-171.